Related Experiment Video
Updated: Jun 23, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Fatigue in sarcoidosis: a systematic review
Willemien P E de Kleijn1, Jolanda De Vries, Elyse E Lower
1CoRPS, Department of Medical Psychology, Tilburg University, Tilburg, the Netherlands.
Sarcoidosis-associated fatigue significantly impacts quality of life. Further research is needed to understand its causes and develop effective treatments for this common complication.
Area of Science:
- Pulmonology
- Rheumatology
- Neurology
Background:
- Fatigue is a prevalent and debilitating symptom in sarcoidosis.
- It is frequently linked to a diminished quality of life for affected individuals.
Purpose of the Study:
- To review and analyze existing literature on sarcoidosis-associated fatigue.
- Focus areas include assessment methods, prevalence, potential causes, and treatment options.
Main Methods:
- Systematic review of published studies on sarcoidosis and fatigue.
- Analysis of data regarding fatigue assessment tools, patient-reported outcomes, and clinical correlations.
Main Results:
- Fatigue is a significant issue in sarcoidosis, negatively impacting quality of life.
- While some studies found no link between clinical factors and fatigue, others reported associations with clinical and psychological parameters.
- Prednisone treatment may be associated with increased fatigue; limited data exists on specific fatigue treatments.
Conclusions:
- Sarcoidosis-associated fatigue is an under-recognized complication requiring greater attention.
- Longitudinal studies are essential to better characterize sarcoidosis fatigue, its quality of life impact, and to explore potential treatments.
Related Concept Videos
Fatigue
Muscle Recovery and Fatigue
Cardiomyopathy VI: Nursing Management
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cardiomyopathy IV: Restrictive Cardiomyopathy
COPD: Management Using Bronchodilators and Corticosteroids